Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Bridgewater, New Jersey 08807


Purpose:

The purpose of this study is to determine if the combination of aspirin plus clopidogrel is more effective than aspirin alone in preventing another heart attack, chest pain, stroke or death in people who have already had a heart attack that was treated with fibrinolytic therapy.


Criteria:

Inclusion Criteria: - STEMI within 12 hours of randomization - Planned treatment with a fibrinolytic agent and aspirin Exclusion Criteria: - Intention of performing coronary angiography within 48 hours of fibrinolysis - Treatment with clopidogrel or ticlopidine within 7 days prior to enrollment, or planned treatment with clopidogrel or ticlopidine. - Contraindication to fibrinolysis - Planned use of a glycoprotein IIb/IIIa inhibitor - Prior CABG - Evidence of cardiogenic shock or acute pulmonary edema requiring intubation or an intraaortic balloon pump - Known renal or hepatic insufficiency


NCT ID:

NCT00714961


Primary Contact:

Principal Investigator
Eugene Braunwald, MD
Brigham and Women's Hospital, Boston, MA, USA


Backup Contact:

N/A


Location Contact:

Bridgewater, New Jersey 08807
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 23, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.